Transitions launches Signature VII lenses with Chromea7 technology

Article

This new lens will replace Transitions Signature VI lenses when available in January 2014.

Las Vegas-Transitions Optical, Inc. has launched Transitions Signature VII lenses with Chromea7 technology. Available in early January 2014, Transitions Signature VII lenses will replace Transitions VI lenses in the Transitions family.

Transitions Optical developed Transitions Signature VII lenses to be more responsive in more situations, testing them in more than 200 conditions representing real-life lighting situations including various temperatures, weather conditions, and geographies. Transitions Signature VII lenses use the patented Chromea7 technology, an exclusive dye formulation that allows the lenses to be more reactive to indirect sunlight and reflected sunlight, and become even darker on hot days.

Transitions Signature VII lenses will be offered in gray and brown.

Visit TransitionsSignature.com order a free launch kit, after completing an online quiz on the site. The launch kit will include a product information sheet, frequently asked questions and answers, and technical product notes.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.